|
Like Lundbeck’s bocunebart, Vedana’s clinical pipeline targets PACAP – an approach that has shown varying levels of success in clinical trials thus far.
|
 |
|
AbCellera will conduct discovery and early-stage research activities on two initial programmes.
|
|
|
Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline candidates in multiple myeloma (MM) at the European Hematology Association Congress (EHA) 2026, held from June 11–14.
|
|
|
The companies aim to create a tablet-form treatment to improve the safety and absorption rates of peptide drugs.
|
|
|
Key opinion leaders interviewed by GlobalData have anticipated the TRIUMPH-1 readout with considerable interest.
|
|
